Literature DB >> 12202502

The Hong Kong progressive lens myopia control study: study design and main findings.

Marion Hastings Edwards1, Roger Wing-Hong Li, Carly Siu-Yin Lam, John Kwok-Fai Lew, Bibianna Sin-Ying Yu.   

Abstract

PURPOSE: To determine whether the use of progressive addition spectacle lenses reduced the progression of myopia, over a 2-year period, in Hong Kong children between the ages of 7 and 10.5 years.
METHODS: A clinical trial was carried out to compare the progression in myopia in a treatment group of 138 (121 retained) subjects wearing progressive lenses (PAL; add +1.50 D) and in a control group of 160 (133 retained) subjects wearing single vision lenses (SV). The research design was masked with random allocation to groups. Primary measurements outcomes were spherical equivalent refractive error and axial length (both measured using a cycloplegic agent).
RESULTS: There were no statistically significant differences between the PAL and the SV groups for of any of the baseline outcome measures. After 2 years there had been statistically significant increases in myopia and axial length in both groups; however, there was no difference in the increases that occurred between the two groups.
CONCLUSIONS: The research design used resulted in matched treatment and control groups. There was no evidence that progression of myopia was retarded by wearing progressive addition lenses, either in terms of refractive error or axial length.

Entities:  

Mesh:

Year:  2002        PMID: 12202502

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  45 in total

Review 1.  Interventions to slow progression of myopia in children.

Authors:  Jeffrey J Walline; Kristina Lindsley; Satyanarayana S Vedula; Susan A Cotter; Donald O Mutti; J Daniel Twelker
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Myopia progression rates in urban children wearing single-vision spectacles.

Authors:  Leslie Donovan; Padmaja Sankaridurg; Arthur Ho; Thomas Naduvilath; Earl L Smith; Brien A Holden
Journal:  Optom Vis Sci       Date:  2012-01       Impact factor: 1.973

3.  The effective add inherent in 2-zone negative lenses inhibits eye growth in myopic young chicks.

Authors:  Yue Liu; Christine Wildsoet
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-31       Impact factor: 4.799

4.  Monovision slows juvenile myopia progression unilaterally.

Authors:  J R Phillips
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

5.  Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria.

Authors: 
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

6.  Accommodation in emmetropic and myopic young adults wearing bifocal soft contact lenses.

Authors:  Janice Tarrant; Holly Severson; Christine F Wildsoet
Journal:  Ophthalmic Physiol Opt       Date:  2008-01       Impact factor: 3.117

Review 7.  Practical applications to modify and control the development of ametropia.

Authors:  P R Sankaridurg; B A Holden
Journal:  Eye (Lond)       Date:  2013-12-06       Impact factor: 3.775

Review 8.  Myopia onset and progression: can it be prevented?

Authors:  Andrea Russo; Francesco Semeraro; Mario R Romano; Rodolfo Mastropasqua; Roberto Dell'Omo; Ciro Costagliola
Journal:  Int Ophthalmol       Date:  2013-09-17       Impact factor: 2.031

9.  Validation of optical coherence tomography-based crystalline lens thickness measurements in children.

Authors:  Bret M Lehman; David A Berntsen; Melissa D Bailey; Karla Zadnik
Journal:  Optom Vis Sci       Date:  2009-03       Impact factor: 1.973

10.  Training regimen involving cyclic induction of pupil constriction during far accommodation improves visual acuity in myopic children.

Authors:  Kenji Yuda; Hiroshi Uozato; Naoto Hara; Wolfram Tetzlaff; Satoru Hisahara; Hiroko Horie; Satomi Nakajima; Hidenori Horie
Journal:  Clin Ophthalmol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.